The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sester, D. P.
Right arrow Articles by Sweet, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sester, D. P.
Right arrow Articles by Sweet, M. J.
The Journal of Immunology, 2006, 177: 4473-4480.
Copyright © 2006 by The American Association of Immunologists, Inc.

CpG DNA Activates Survival in Murine Macrophages through TLR9 and the Phosphatidylinositol 3-Kinase-Akt Pathway1

David P. Sester*, Kristian Brion*, Angela Trieu*, Helen S. Goodridge*, Tara L. Roberts*, Jasmyn Dunn*, David A. Hume*, Katryn J. Stacey*,{dagger} and Matthew J. Sweet2,*,{dagger}

* Cooperative Research Centre for Chronic Inflammatory Diseases and Special Research Centre for Functional and Applied Genomics, Institute for Molecular Bioscience, University of Queensland, and {dagger} School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Queensland, Australia

Bacterial CpG-containing (CpG) DNA promotes survival of murine macrophages and triggers production of proinflammatory mediators. The CpG DNA-induced inflammatory response is mediated via TLR9, whereas a recent study reported that activation of the Akt prosurvival pathway occurs via DNA-dependent protein kinase (DNA-PK) and independently of TLR9. We show, in this study, that Akt activation and survival of murine bone marrow-derived macrophages (BMM) triggered by CpG-containing phosphodiester oligodeoxynucleotides or CpG-containing phosphorothioate oligodeoxynucleotides was completely dependent on TLR9. In addition, survival triggered by CpG-containing phosphodiester oligodeoxynucleotides was not compromised in BMM from SCID mice that express a catalytically inactive form of DNA-PK. CpG DNA-induced survival of BMM was inhibited by the PI3K inhibitor, LY294002, but not by the MEK1/2 inhibitor, PD98059. The effect of LY294002 was specific to survival, because treatment of BMM with LY294002 affected CpG DNA-induced TNF-{alpha} production only modestly. Therefore, CpG DNA activates macrophage survival via TLR9 and the PI3K-Akt pathway and independently of DNA-PK and MEK-ERK.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the National Health and Medical Research Council of Australia (ID 301211 and ID 301210).

2 Address correspondence and reprint requests to Dr. Matthew J. Sweet, Institute for Molecular Bioscience, University of Queensland, St. Lucia, Brisbane, Queensland, 4072, Australia. E-mail address: m.sweet{at}imb.uq.edu.au

3 Abbreviations used in this paper: DC, dendritic cell; DNA-PK, DNA-dependent protein kinase; PO-ODN, phosphodiester oligodeoxynucleotide; PS-ODN, phosphorothioate oligodeoxynucleotide; BMM, bone marrow-derived macrophage; AO-1, activating oligonucleotide-1; NAO-1, nonactivating oligonucleotide-1; EC DNA, Escherichia coli genomic DNA.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A.-C. Iversen, B. Steinkjer, N. Nilsen, J. Bohnhorst, S. H. Moen, R. Vik, P. Stephens, D. W. Thomas, C. A. Benedict, and T. Espevik
A Proviral Role for CpG in Cytomegalovirus Infection
J. Immunol., May 1, 2009; 182(9): 5672 - 5681.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Bekeredjian-Ding, A. Doster, M. Schiller, P. Heyder, H.-M. Lorenz, B. Schraven, U. Bommhardt, and K. Heeg
TLR9-Activating DNA Up-Regulates ZAP70 via Sustained PKB Induction in IgM+ B Cells
J. Immunol., December 15, 2008; 181(12): 8267 - 8277.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Xiong, S. Gharagozlou, I. Vengco, W. Chen, and J. R. Ohlfest
Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis
Clin. Cancer Res., September 1, 2008; 14(17): 5484 - 5493.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Zheng, N. Asprodites, A. H. Keene, P. Rodriguez, K. D. Brown, and E. Davila
TLR9 engagement on CD4 T lymphocytes represses {gamma}-radiation-induced apoptosis through activation of checkpoint kinase response elements
Blood, March 1, 2008; 111(5): 2704 - 2713.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Guiducci, C. Ghirelli, M.-A. Marloie-Provost, T. Matray, R. L. Coffman, Y.-J. Liu, F. J. Barrat, and V. Soumelis
PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation
J. Exp. Med., February 18, 2008; 205(2): 315 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yotsumoto, K. Saegusa, and Y. Aramaki
Endosomal Translocation of CpG-Oligodeoxynucleotides Inhibits DNA-PKcs-Dependent IL-10 Production in Macrophages
J. Immunol., January 15, 2008; 180(2): 809 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Lattin, D. A. Zidar, K. Schroder, S. Kellie, D. A. Hume, and M. J. Sweet
G-protein-coupled receptor expression, function, and signaling in macrophages
J. Leukoc. Biol., July 1, 2007; 82(1): 16 - 32.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Schroder, M. Lichtinger, K. M. Irvine, K. Brion, A. Trieu, I. L. Ross, T. Ravasi, K. J. Stacey, M. Rehli, D. A. Hume, et al.
PU.1 and ICSBP control constitutive and IFN-{gamma}-regulated Tlr9 gene expression in mouse macrophages
J. Leukoc. Biol., June 1, 2007; 81(6): 1577 - 1590.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.